Dr. Shipley graduated the medical school from the Marshall University Joan C. Edwards. She did her internship at the Allegheny General Hospital-Western Pennsylvania Hospital and completed her residency program at the Charleston Area Medical Center. A fellowship followed at the Wake Forest University soon after that. She is specialized in Medical Oncology and board certified in Oncology. Dr. Shipley has been in practice for more than 20 years and is affiliated with the TriStar Centennial Medical Center. During her career, she has also contributed to various publications of medical interest.
Marshall University Joan C. Edwards
Allegheny General Hospital - Western Pennsylvania Hospital
Charleston Area Medical Center
Wake Forest University
American Board of Internal Medicine - Oncology
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Yardley DA, Shipley DL, Peacock NW, Shastry M, Midha R, Priego VM, Hainsworth JD; Breast Cancer Res. Treat.. 2015-08-01See more >>
High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium.
Hainsworth, J. D.,Shipley, D. L.,Reeves, J.,Arrowsmith, E. R.,Barnes, E. K.,Waterhouse, D. M.; Clin Genitourin Cancer. 2013 Sep.See more >>
11 citations Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.
Hainsworth, J. D.,Waterhouse, D. M.,Penley, W. C.,Shipley, D. L.,Thompson, D. S.,Webb, C. D.,Anthony Greco, F.; Cancer Invest.. 2013 Jun.See more >>